VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 29 filers reported holding VECTIVBIO HLDG AG in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $87,661,537 | +99.8% | 5,156,561 | 0.0% | 1.59% | +84.4% |
| Q1 2023 | $43,882,334 | -27.7% | 5,156,561 | -26.4% | 0.86% | -25.8% |
| Q4 2022 | $60,714,451 | +56.3% | 7,006,861 | +8.2% | 1.16% | +61.0% |
| Q3 2022 | $38,841,000 | +11.1% | 6,473,561 | 0.0% | 0.72% | +13.9% |
| Q2 2022 | $34,957,000 | +39.2% | 6,473,561 | +21.4% | 0.63% | +55.5% |
| Q1 2022 | $25,108,000 | -2.1% | 5,330,704 | +2.0% | 0.41% | +23.3% |
| Q4 2021 | $25,649,000 | -35.2% | 5,223,804 | +2.0% | 0.33% | -24.1% |
| Q3 2021 | $39,578,000 | -33.7% | 5,123,304 | 0.0% | 0.44% | -28.0% |
| Q2 2021 | $59,738,000 | – | 5,123,304 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,084,310 | $14,527,000 | 6.18% |
| Novo Holdings A/S | 3,380,402 | $15,922,000 | 0.84% |
| Cormorant Asset Management, LP | 2,078,485 | $9,790,000 | 0.75% |
| Orbimed Advisors | 5,330,704 | $25,108,000 | 0.41% |
| Bpifrance SA | 2,806,217 | $13,217,000 | 0.37% |
| Eventide Asset Management | 2,339,044 | $10,994,000 | 0.17% |
| Tekla Capital Management LLC | 756,502 | $3,556,000 | 0.12% |
| Canaan Partners XI LLC | 37,051 | $175,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 393,365 | $1,849,000 | 0.02% |
| Citadel Advisors | 2,722,646 | $12,797,000 | 0.00% |